<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02343770</url>
  </required_header>
  <id_info>
    <org_study_id>9355</org_study_id>
    <nct_id>NCT02343770</nct_id>
  </id_info>
  <brief_title>Biomarkers in Idiopathic Juvenile Arthritis</brief_title>
  <official_title>Usefulness of Protoarray速Microarray for Identifying Biomarkers in Idiopathic Juvenile Arthritis Antinuclear Antibodies Positive.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Juvenile idiopathic arthritis (JIA) is the most common form of arthritis in children. The
      etiology is unknown. Several types of arthritis fall under the JIA heading. Oligoarticular
      JIA with antinuclear antibodies affects about half of all children. There 's no specific
      markers. Our purpose is to identify new markers in this pathology. The ProtoArray速Human
      Protein Microarray allows rapid and efficient detection of protein interaction using a
      suitable protein or small molecule probe. The investigators hope so detect novel potential
      autoantigen biomarkers specific in JIA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We select 10 patients with inclusion criteria and 10 controls. We analyse their blood sample
      (5ml). The ProtoArray速 Microarray allows to detect novel protein-protein interactions, to
      rapidly perform serum profiling using a sensitive method to detect potential autoantigen
      biomarkers. The ProtoArray速 Human Protein Microarray is a high-density protein microarray
      containing thousands of purified human proteins for protein interaction screening.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>identification of specific autoantigen biomarkers</measure>
    <time_frame>1 day</time_frame>
    <description>Identify blood sampling biomarkers of juvenile idiopathic arthritis</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Idiopathic Juvenile Arthritis</condition>
  <arm_group>
    <arm_group_label>idiopathic juvenile arthritis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>blood sample</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>blood sample</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood sample for identifying biomarkers</intervention_name>
    <arm_group_label>idiopathic juvenile arthritis</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for experimental group :

          -  child age from 2 to 16 years

          -  Oligoarticular JIA with antinuclear antibodies

          -  with or without uveitis

        Exclusion criteria for experimental group :

          -  immunosuppressive and biological therapy

        Inclusion Criteria for control group :

          -  child age from 2 to 16 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cardiology paediatric consultation, Arnaud de Villeneuve Hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aurelia CARBASSE, MD</last_name>
      <phone>+33 4 67 33 66 34</phone>
      <email>a-carbasse@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>aurelia carbasse, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2015</study_first_submitted>
  <study_first_submitted_qc>January 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 22, 2015</study_first_posted>
  <last_update_submitted>September 4, 2015</last_update_submitted>
  <last_update_submitted_qc>September 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Juvenile</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

